NL6610324A - - Google Patents
Info
- Publication number
- NL6610324A NL6610324A NL6610324A NL6610324A NL6610324A NL 6610324 A NL6610324 A NL 6610324A NL 6610324 A NL6610324 A NL 6610324A NL 6610324 A NL6610324 A NL 6610324A NL 6610324 A NL6610324 A NL 6610324A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F9/00—Component parts of dredgers or soil-shifting machines, not restricted to one of the kinds covered by groups E02F3/00 - E02F7/00
- E02F9/20—Drives; Control devices
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Mining & Mineral Resources (AREA)
- Civil Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Structural Engineering (AREA)
- Molecular Biology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DET0029055 | 1965-07-23 | ||
| DET0032992 | 1967-01-16 | ||
| DET0032993 | 1967-01-16 | ||
| DET0032994 | 1967-01-16 | ||
| DET0032991 | 1967-01-16 | ||
| DET0032990 | 1967-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6610324A true NL6610324A (nl) | 1967-01-24 |
Family
ID=27512321
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6610324A NL6610324A (nl) | 1965-07-23 | 1966-07-22 | |
| NL6800589A NL6800589A (nl) | 1965-07-23 | 1968-01-15 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6800589A NL6800589A (nl) | 1965-07-23 | 1968-01-15 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE684415A (nl) |
| BR (1) | BR6681517D0 (nl) |
| DE (1) | DE1620508A1 (nl) |
| ES (9) | ES329299A1 (nl) |
| FR (3) | FR1498465A (nl) |
| GB (1) | GB1140387A (nl) |
| NL (2) | NL6610324A (nl) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001090092A1 (en) * | 2000-05-22 | 2001-11-29 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7094792B2 (en) | 2001-11-22 | 2006-08-22 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7547786B2 (en) | 2003-11-12 | 2009-06-16 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
| US8541592B2 (en) | 2005-11-22 | 2013-09-24 | Amgen Inc. | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847264A (en) * | 1982-07-21 | 1989-07-11 | Rorer Pharmaceutical Corporation | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
| GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
| EP0192098B1 (de) | 1985-02-06 | 1991-08-21 | Boehringer Ingelheim Kg | Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels |
| GB2173187B (en) * | 1985-03-23 | 1988-05-18 | Erba Farmitalia | Condensed 2-substituted thiazole derivatives |
| US5060904A (en) * | 1987-05-01 | 1991-10-29 | David Hegarty | Multi-positionable support stand with movable center of gravity and article holding means |
| WO1999029318A1 (en) * | 1997-12-11 | 1999-06-17 | Biochem Pharma Inc. | Antiviral compounds |
| AR041952A1 (es) | 2002-11-14 | 2005-06-01 | Novartis Ag | N-sulfonilaminotiazol |
| CL2004000553A1 (es) | 2003-03-20 | 2005-02-04 | Actelion Pharmaceuticals Ltd | Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende. |
| EP2379565A1 (en) * | 2008-12-19 | 2011-10-26 | Schering Corporation | Piperidine and piperazine derivatives and methods of use thereof |
| EP2414340A1 (en) * | 2009-04-03 | 2012-02-08 | Dainippon Sumitomo Pharma Co., Ltd. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| TW201831478A (zh) | 2016-12-02 | 2018-09-01 | 瑞士商赫孚孟拉羅股份公司 | 雙環醯胺化合物及其使用方法 |
| FI3652178T3 (fi) | 2017-07-14 | 2024-03-19 | Hoffmann La Roche | Bisyklisiä ketoniyhdisteitä ja niiden käyttömenetelmiä |
| MA50503A (fr) | 2017-10-31 | 2020-09-09 | Hoffmann La Roche | Sulfones et sulfoxydes bicycliques et procédés d'utilisation associés |
| CN109134510A (zh) * | 2018-11-13 | 2019-01-04 | 井冈山大学 | 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5，4-c]吡啶的新方法 |
-
1965
- 1965-07-23 DE DE19651620508 patent/DE1620508A1/de active Pending
-
1966
- 1966-07-15 GB GB31938/66A patent/GB1140387A/en not_active Expired
- 1966-07-20 ES ES329299A patent/ES329299A1/es not_active Expired
- 1966-07-20 BE BE684415D patent/BE684415A/xx unknown
- 1966-07-22 FR FR70539A patent/FR1498465A/fr not_active Expired
- 1966-07-22 FR FR70538A patent/FR6013M/fr not_active Expired
- 1966-07-22 NL NL6610324A patent/NL6610324A/xx unknown
- 1966-07-22 BR BR181517/66A patent/BR6681517D0/pt unknown
-
1968
- 1968-01-15 ES ES349317A patent/ES349317A1/es not_active Expired
- 1968-01-15 ES ES349318A patent/ES349318A1/es not_active Expired
- 1968-01-15 ES ES349320A patent/ES349320A1/es not_active Expired
- 1968-01-15 ES ES349316A patent/ES349316A1/es not_active Expired
- 1968-01-15 ES ES349322A patent/ES349322A1/es not_active Expired
- 1968-01-15 ES ES349319A patent/ES349319A1/es not_active Expired
- 1968-01-15 ES ES349314A patent/ES349314A1/es not_active Expired
- 1968-01-15 ES ES349321A patent/ES349321A1/es not_active Expired
- 1968-01-15 NL NL6800589A patent/NL6800589A/xx unknown
- 1968-01-16 FR FR136259A patent/FR94123E/fr not_active Expired
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7618961B2 (en) | 2000-05-22 | 2009-11-17 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| WO2001090094A1 (en) * | 2000-05-22 | 2001-11-29 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7030135B2 (en) | 2000-05-22 | 2006-04-18 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| WO2001090092A1 (en) * | 2000-05-22 | 2001-11-29 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7132436B2 (en) | 2000-05-22 | 2006-11-07 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| US7094792B2 (en) | 2001-11-22 | 2006-08-22 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7671051B2 (en) | 2001-11-22 | 2010-03-02 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| US7547786B2 (en) | 2003-11-12 | 2009-06-16 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
| US7678910B2 (en) | 2003-11-12 | 2010-03-16 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]Pyridine-2-carboxylic acid |
| EP2266991A2 (en) | 2003-11-12 | 2010-12-29 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
| EP2266992A2 (en) | 2003-11-12 | 2010-12-29 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
| US7880005B2 (en) | 2003-11-12 | 2011-02-01 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid |
| US8058440B2 (en) | 2003-11-12 | 2011-11-15 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid |
| US8541592B2 (en) | 2005-11-22 | 2013-09-24 | Amgen Inc. | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
Also Published As
| Publication number | Publication date |
|---|---|
| NL6800589A (nl) | 1968-07-17 |
| ES349320A1 (es) | 1969-04-01 |
| ES349314A1 (es) | 1969-04-01 |
| FR94123E (fr) | 1969-07-04 |
| ES349321A1 (es) | 1969-04-01 |
| ES349319A1 (es) | 1969-04-01 |
| BR6681517D0 (pt) | 1973-12-27 |
| ES349318A1 (es) | 1969-04-01 |
| ES349317A1 (es) | 1969-04-01 |
| ES329299A1 (es) | 1968-02-16 |
| GB1140387A (en) | 1969-01-15 |
| FR6013M (nl) | 1968-05-06 |
| FR1498465A (fr) | 1967-10-20 |
| DE1620508A1 (de) | 1969-09-18 |
| ES349322A1 (es) | 1969-04-01 |
| ES349316A1 (es) | 1969-04-01 |
| BE684415A (nl) | 1967-01-20 |